Comparison of diffusion tensor-based tractography and quantified brain atrophy for analyzing demyelination and axonal loss in MS

Journal of Neuroimaging

Volumn 20, Issue 4, 2010, Pages 334-344

  Fink, Frauke ^a,b   Klein, Jan ^c   Lanz, Michael ^a   Mitrovics, Tibor ^a   Lentschig, Markus ^d   Hahn, Horst K ^c   Hildebrandt, Helmut ^a,b  

^a KLINIKUM BREMEN OST   (Germany)

^b UNIVERSITY OF OLDENBURG   (Germany)

^c FRAUNHOFER MEVIS   (Germany)

^d MR und PET/CT Zentrum Bremen Mitte   (Germany)

Author keywords

Brain atrophy; Diffusion tensor imaging; Multiple sclerosis; Parallel and perpendicular diffusivity; Tractography

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATION; DIFFUSION TENSOR IMAGING; DISCRIMINANT ANALYSIS; DISEASE DURATION; FEMALE; FRACTIONAL ANISOTROPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NERVE FIBER; NEUROIMAGING; PREDICTION;

ADULT; AGED; AGED, 80 AND OVER; ATROPHY; BRAIN; DEMYELINATING DISEASES; DIFFUSION MAGNETIC RESONANCE IMAGING; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RETROGRADE DEGENERATION;

EID: 78349287364     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2009.00377.x     Document Type: Article

References (50)

1. Zivadinov R. Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis? Neurology 2007;68:S72-S82.
2. Miller DH, Barkhof F, Frank JA, et al. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 2002;125:1676-1695.
3. Bermel RA, Bakshi R. The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol 2006;5:158-170.
4. Kalkers NF, Bergers E, Castelijns JA, et al. Optimizing the association between disability and biological markers in MS. Neurology 2000;57:1253-1258.
5. Lanz M, Hahn HK, Hildebrandt H. Brain atrophy and cognitive impairment in multiple sclerosis: a review. J Neurol 2007;254(Suppl 2):II43-II48.
6. Tedeschi G, Dinacci D, Lavorgna L, et al. Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability. J Neurol Sci 2007;263:15-19.
7. Rovaris M, Filippi M. Diffusion tensor MRI in multiple sclerosis. J Neuroimaging 2007;17(Suppl 1):27S-30S.
8. Hardmeier M, Wagenpfeil S, Freitag P, et al., European IFN-1a in Relapsing MS Dose Comparison Trial Study Group. Rate of brain atrophy in relapsing MS decreases during treatment with IFNbeta-1a. Neurology 2005;64:236-240.
9. Ciccarelli O, Catani M, Johansen-Berg H, et al. Diffusion-based tractography in neurological disorders: concepts, applications, and future developments. Lancet Neurol 2008;7:715-727.
10. Pagani E, Bammer R, Horsfield MA, et al. Diffusion MR imaging in multiple sclerosis: technical aspects and challenges. AJNR Am J Neuroradiol 2007;28:411-420.
11. Rovaris M, Filippi M. MR-based technology for in vivo detection, characterization, and quantification of pathology of relapsing-remitting multiple sclerosis. J Rehabil Res Dev 2002;39:243-259.
12. Goldberg-Zimring D, Warfield SK. Novel image processing techniques to better understand white matter disruption in multiple sclerosis. Autoimmun Rev 2006;5:544-548.
13. Ge Y, Law M, Grossman RI. Applications of diffusion tensor MR imaging in multiple sclerosis. Ann N Y Acad Sci 2005;1064:202-219.
14. Horsfield MA, Jones DK. Applications of diffusion-weighted and diffusion tensor MRI to white matter diseases - a review. NMR Biomed 2002;15:570-577.
15. Makris N, Kennedy DN, McInerney S, et al. Segmentation of subcomponents within the superior longitudinal fascicle in humans: a quantitative, in vivo, DT-MRI study. Cerebral Cortex 2005;15:854-869.
16. Schmierer K, Wheeler-Kingshott CA, Boulby PA, et al. Diffusion tensor imaging of post mortem multiple sclerosis brain. NeuroImage 2007;35:467-477.
17. Budde MD, Kim JH, Liang HF, et al. Axonal injury detected by in vivo diffusion tensor imaging correlates with neurological disability in a mouse model of multiple sclerosis. NMR Biomed 2008;21:589-597.
18. Budde MD, Kim JH, Liang HF, et al. Toward accurate diagnosis of white matter pathology using diffusion tensor imaging. Magn Reson Med 2007;57:688-695.
19. Hui ES, Fu QL, So KF, et al. Diffusion tensor MR study of optic nerve degeneration in glaucoma. Conf Proc IEEE Eng Med Biol Soc 2007;4312-4315.
20. DeBoy CA, Zhang J, Dike S, et al. High resolution diffusion tensor imaging of axonal damage in focal inflammatory and demyelinating lesions in rat spinal cord. Brain 2007;130:2199-2210.
21. Sun SW, Liang HF, Schmidt RE, et al. Selective vulnerability of cerebral white matter in a murine model of multiple sclerosis detected using diffusion tensor imaging. Neurobiol Dis 2007;28:30-38.
22. Sun SW, Liang HF, Le TQ, et al. Differential sensitivity of in vivo and ex vivo diffusion tensor imaging to evolving optic nerve injury in mice with retinal ischemia. NeuroImage 2006;32:1195-1204.
23. Kim JH, Budde MD, Liang HF, et al. Detecting axon damage in spinal cord from a mouse model of multiple sclerosis. Neurobiol Dis 2006;21:626-632.
24. Song SK, Yoshino J, Le TQ, et al. Demyelination increases radial diffusivity in corpus callosum of mouse brain. NeuroImage 2005;26:132-140.
25. Lowe MJ, Beall EB, Sakaie KE, et al. Resting state sensorimotor functional connectivity in multiple sclerosis inversely correlates with transcallosal motor pathway transverse diffusivity. Hum Brain Mapp 2008;29:818-827.
26. Lin F, Yu C, Jiang T, et al. Diffusion tensor tractography-based group mapping of the pyramidal tract in relapsing-remitting multiple sclerosis patients. AJNR Am J Neuroradiol 2007;28:278-282.
27. Rosendaal SD, Geurts JJ, Vrenken H, et al. Regional DTI differences in multiple sclerosis patients. NeuroImage 2009;15;44(4):1397-403.
28. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-127.
29. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
30. Hahn HK, Klein J, Nimsky C, et al. Uncertainty in diffusion tensor based fibre tracking, medical technologies in neurosurgery, series. Acta Neurochir (Wien) 2006;Suppl. 98:33-41.
31. Hahn HK. Morphological volumetry - theory, concepts, and application to quantitative medical imaging. Ph.D. thesis 2005;117-134.
32. Hahn HK, Millar WS, Klinghammer O, et al. A reliable and efficient method for cerebral ventricular volumetry in pediatric neuroimaging. Methods Inf Med 2004;43:376-382.
33. Lukas C, Hahn HK, Bellenberg B, et al. Sensitivity and reproducibility of a new fast 3D segmentation technique for clinical MR-based brain volumetry in multiple sclerosis. Neuroradiology 2004;46:906-915.
34. MeVisLab development environment for medical image processing and visualization. Version 2.0 (2008, not released yet); Available at:
35. Schlüter M, Konrad-Verse O, et al. White matter lesion phantom for diffusion tensor data and its application to the assessment of fiber tracking. Medical imaging 2005, physiology, function, and structure from medical images. Proc SPIE 2005;5746:835-844.
36. Weinstein DM, Kindlmann GL, Lundberg E. Tensorlines: advection diffusion based propagation through diffusion tensor fields. IEEEVisual Proc 1999;San Fransisco:249-253
37. Klein J, Hermann S, Konrad O, et al. Automatic quantification of DTI parameters along fiber bundles. Proc Image Process Med 2007;272-276.
38. Mori S, Van Zijl PCM, Wakana S, et al. MRI Atlas of Human White Matter. Oxford Elsevier; 2005.
39. Horakova D, Cox JL, Havrdova E, et al. Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study. J Neurol Neurosurg Psychiatry 2008;79:407-414.
40. Bermel, RA, Bakshi R, Tjoa C, et al. Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis. Arch Neurol 2002;59:275-280.
41. Dalton CM, Chard DT, Davies GR, et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 2004;127:1101-1107.
42. Lenzi D, Conte A, Mainero C, et al. Effect of corpus callosum damage on ipsilateral motor activation in patients with multiple sclerosis: a functional and anatomical study. Hum Brain Mapp 2007;28:636-644.
43. Hasan KM, Gupta RK, Santos RM, et al. Diffusion tensor fractional anisotropy of the normal-appearing seven segments of the corpus callosum in healthy adults and relapsing-remitting multiple sclerosis patients. J Magn Reson Imaging 2005;21(6):735-743.
44. Coombs BD, Best A, Brown MS, et al. Multiple sclerosis pathology in the normal and abnormal appearing white matter of the corpus callosum by diffusion tensor imaging. Mult Scler 2004;10:392-397.
45. Ge Y, Law M, Johnson G, et al. Preferential occult injury of corpus callosum in multiple sclerosis measured by diffusion tensor imaging. J Magn Reson Imaging 2004;20:1-7.
46. Oh J, Henry RG, Genain C, et al. Mechanisms of normal appearing corpus callosum injury related to pericallosal T1 lesions in multiple sclerosis using directional diffusion tensor and 1H MRS imaging. J Neurol Neurosurg Psychiatry 2004;75:1281-1286.
47. Reich DS, Smith SA, Zackowski KM, et al. Multiparametric magnetic resonance imaging analysis of the corticospinal tract in multiple sclerosis. NeuroImage 2007;38:271-279.
48. Trip SA, Wheeler-Kingshott C, Jones SJ, et al. Optic nerve diffusion tensor imaging in optic neuritis. NeuroImage 2006;30:498-505.
49. Sidaros A, Engberg AW, Sidaros K, et al. Diffusion tensor imaging during recovery from severe traumatic brain injury and relation to clinical outcome: a longitudinal study. Brain 2008;131:559-572.
50. Mac Donald CL, Dikranian K, et al. Diffusion tensor imaging reliably detects experimental traumatic axonal injury and indicates approximate time of injury. J Neurosci 2007;27:11869-11876.